Condition (MeSH)
Fusariosis
ClinicalTrials.gov lists 6 trials for Fusariosis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
6 of the 6 trials are tagged with Fusariosis itself; the rest are tagged with a narrower condition beneath it.
When did Fusariosis trials start? (6)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2023 | 1 |
| 2020 | 1 |
| 2015 | 1 |
| 2010 | 1 |
| 2008 | 1 |
| 2007 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 6 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Fusariosis trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Not applicable | 2 |
| Observational | 4 |
How many Fusariosis trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 4 |
| Terminated | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Fusariosis? (9)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Propranolol is efficacious against <i>Aspergillus</i> and <i>Fusarium</i> corneal isolates <i>in vitro</i> and in a murine model of <i>Aspergillus</i> keratitis. | Antimicrobial agents and chemotherapy | 2025 | Yes |
| Disseminated Fusariosis in Immunocompromised Children-Analysis of Recent Cases Identified in the Global Fungiscope Registry. | The Pediatric infectious disease journal | 2017 | Yes |
| Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II. | JAMA ophthalmology | 2017 | Yes |
| Improvement in the outcome of invasive fusariosis in the last decade. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2014 | Yes |
| Riboflavin/ultravoilet light-mediated crosslinking for fungal keratitis. | The British journal of ophthalmology | 2013 | Yes |
Showing 5 of 9 publications.
Prevalence (3)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Fusariosis | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Fusariosis | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Fusariosis | Point prevalence | Unknown | Worldwide | Not stated | Unspecified |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Fusariosis | 228119 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Fusariosis | 228119 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.